The Israeli medical device company, iTind, has developed a clinically-proven treatment for BPH that relieves lower urinary tract symptoms without the need for surgery or prescription medication. The procedure reshapes the prostatic urethra, allowing urine to flow freely without tissue removal or permanent implants. It offers rapid symptom relief, preserves sexual function, and has minimal downtime, with the temporary implant removed after 5 to 7 days. Clinical studies have demonstrated durable results for up to 3 years.